Abstract
Effective therapy options for pneumoconiosis are lacking. Traditional Chinese medicine (TCM) presents a favorable prospect in the treatment of pneumoconiosis. A pilot study on TCM syndrome differentiation can evaluate the clinical efficacy and safety of TCM and lay a foundation for further clinical research. A double-blind, randomized, and placebo-controlled trial was conducted for 24 weeks, in which 96 patients with pneumoconiosis were randomly divided into the control and treatment groups. Symptomatic treatment was conducted for the two groups. The treatment group was treated with TCM syndrome differentiation, and the control group was treated with placebo. The primary outcomes were the six-minute walking distance (6MWD) and the St. George Respiratory Questionnaire (SGRQ) score. The secondary outcomes were the modified British Medical Research Council Dyspnea Scale (mMRC), Chronic Obstructive Pulmonary Disease Assessment Test (CAT), Hospital Anxiety and Depression Scale (HADS), and pulmonary function. Only 83 patients from the 96 patients with pneumoconiosis finished the study. For the primary outcome, compared with the control groups, the treatment group showed a significantly increased 6MWD (407.90 m vs. 499.51 m; 95% confidence interval (CI) 47.25 to 135.97; P < 0.001) and improved SGRQ total score (44.48 vs. 25.67; 95% CI −27.87 to −9.74; P < 0.001). The treatment group also significantly improved compared with the control group on mMRC score (1.4 vs. 0.74; 95% CI −1.08 to −0.23; P =0.003), CAT score (18.40 vs. 14.65; 95% CI −7.07 to −0.43; P =0.027), and the total symptom score (7.90 vs. 5.14; 95% CI −4.40 to −1.12; P < 0.001). No serious adverse events occurred. This study showed that TCM syndrome differentiation and treatment had a favorable impact on the exercise endurance and quality of life of patients with pneumoconiosis.
Similar content being viewed by others
References
Occupational Lung Disease Group of Labor Hygiene and Occupational Diseases Branch of Chinese Preventive Medicine Association. Consensus of Chinese experts on pneumoconiosis treatment (2018). J Environ Occup Med (Huan Jing Yu Zhi Ye Yi Xue) 2018; 35(8): 677–689 (in Chinese)
National Health and Family Planning Commission of the People’s Republic of China. National occupational health standards: GBZ 70–2015. Beijing: China Quality and Standards Publishing & Media Co., Ltd., 2015
Mlika M, Adigun R, Beenish SB. Silicosis (Coal Worker Pneumoconiosis). Treasure Island (FL): StatPearls Publishing, 2020
Leonard R, Zulfikar R, Stansbury R. Coal mining and lung disease in the 21st century. Curr Opin Pulm Med 2020; 26(2): 135–141
Blackley DJ, Halldin CN, Laney AS. Continued increase in prevalence of coal workers’ pneumoconiosis in the United States, 1970–2017. Am J Public Health 2018; 108(9): 1220–1222
National Health Commission of the People’s Republic of China. Statistical bulletin on the development of health care in China in 2018. http://www.nhc.gov.cn/guihuaxxs/s10748/2019.5/9b8d52727cf346049de8acce25ffcbd0.shtml (accessed July 6, 2020)
Yang QY, Wang HJ, Liu LH, Zhang XJ, Zou XX. Prevalence of silicosis among workers exposed to silica dust in China during 2002–2016: a meta-analysis. Chin J Ind Med (Zhongguo Gong Ye Yi Xue Za Zhi) 2018; 31(4): 307–308 (in Chinese)
Zhu XJ, Xiao P, Wang D, Wang HF, Wang YH, Yu Y, Yin P, Li J, Li J, Zhou MG, Li T. Analysis on disease burden of pneumoconiosis in Chinese population from 1990 to 2017. Chin J Ind Med (Zhongguo Gong Ye Yi Xue Za Zhi) 2019; 32(05): 341–346 (in Chinese)
Tang H, Wang YD, Chen H, Xu JJ, Li BP. Case fatality rate in patients with pneumoconiosis in China: a meta-analysis. Chin J Ind Hyg Occu Dis (Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi) 2015; 33(3): 229–232 (in Chinese)
Zhao G. The analysis of social and economic impact of pneumoconiosis in our country. Master thesis. Beijing: China University of Geosciences, 2011 (in Chinese)
Wang XY, Zhang JB, Wei CL, Wan WJ, Han YC, Zhang BW. Effect of large volume whole lung lavage on respiratory function of patients with pneumoconiosis: a systematic review and meta-analysis. J Changzhi Med Coll (Changzhi Yi Xue Yuan Xue Bao) 2016; 30(2): 104–107 (in Chinese)
Mao WJ, Chen JY, Zheng MF, Ye SG, Liu F, He YJ, Wu B, Zhang J. Lung transplantation for end-stage silicosis. J Occup Environ Med 2011; 53(8): 845–849
Spitalieri P, Quitadamo MC, Orlandi A, Guerra L, Giardina E, Casavola V, Novelli G, Saltini C, Sangiuolo F. Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells. Eur Respir J 2012; 39(2): 446–457
Weiss DJ. Stem cells, cell therapies, and bioengineering in lung biology and diseases. Comprehensive review of the recent literature 2010–2012. Ann Am Thorac Soc 2013; 10(5): S45–S97
Song PP, Liu J, Xiao H, Ma XY, Zhang SQ, Chen YX. Clinical study on traditional Chinese medicine syndrome differentiation and treatment of pneumoconiosis. Chin J Ind Hyg Occup Dis (Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi) 2019; 37(3): 186–188 (in Chinese)
Wang HJ, Ma GQ. Introduction to Professor Ma Guiqin’s experience in treatment of occupational pneumoconiosis. China J Chin Materia Medica (Zhongguo Zhong Yao Za Zhi) 2019; 44(13): 2871–2874 (in Chinese)
Tang CY, Qiu XX, Zhou HZ, Wu DH, Gan WZ. Influencing factors and quality of life in patients with occupational pneumoconiosis. China Occup Med (Zhongguo Zhi Ye Yi Xue) 2016; 43(03): 292–295 (in Chinese)
Wang MH, Li JS, Li SY, Xie Y. Effects of comprehensive therapy based on traditional Chinese medicine patterns on older patients with chronic obstructive pulmonary disease: a subgroup analysis from a four-center, randomized, controlled study. Front Med 2014; 8(3): 368–375
Shao R, Wang FJ, Lyu M, Yang J, Zhang P, Zhu Y. Ability to suppress TGF-β-activated myofibroblast differentiation distinguishes the anti-pulmonary fibrosis efficacy of two danshen-containing Chinese herbal medicine prescriptions. Front Pharmacol 2019; 10: 412
Du H, Wang YH, Shi YM, Yu J, Sun W, Zhang YQ. Effect of traditional Chinese medicine on inflammatory mediators in pediatric asthma. Mediators Inflamm 2016; 2016: 5143703
Wang X. Clinical study on treatment of pneumoconiosis with Xuanfei Dichen Tang. Master thesis. Jinan: Shandong University of Traditional Chinese Medicine, 2011 (in Chinese)
Hu J. Effect of TCM syndrome differentiation on quality of life and biological index of pneumoconiosis. Master thesis. Qingdao: Qingdao University, 2017 (in Chinese)
Zhang RY, Wang D, Wu JP, Li XL, Li CX, Guo CF. Randomized controlled clinical trials for acupuncture treatment of pneumoconiosis. Acupunct Res (Zhen Ci Yan Jiu) 2016; 41(2): 163–168 (in Chinese)
Zhao HL, Xie Y, Li JS. Analysis of registration data for clinical trials of pneumoconiosis. Chin J Indl Hyg Occup Dis (Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi) 2020; 38(1): 20–23 (in Chinese)
Holland AE, Hill CJ, Rasekaba T, Lee A, Naughton MT, McDonald CF. Updating the minimal important difference for six-minute walk distance in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 2010; 91(2): 221–225
Nathan SD, du Bois RM, Albera C, Bradford WZ, Costabel U, Kartashov A, Noble PW, Sahn SA, Valeyre D, Weycker D, King TE Jr. Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis. Respir Med 2015; 109(7): 914–922
Ma YH, Cui P, Li P, Liu GF, Jia YW, Zhou X, Gu XX, Su WG. Observation on the efficacy of compound cream mulberry leaf mixture combined with traditional Chinese medicine constitutional intervention on pneumoconiosis. Mod J Integr Tradit Chin West Med (Xian Dai Zhong Xi Yi Jie He Za Zhi) 2020; 29(12): 1284–1287, 1330 (in Chinese)
Sun SC, Li WT, Lin DW, Hou SS, Wu XW, Shen XJ, Li YW, Zhang MM. Clinical observation on the crude herb moxibustion combined with Bufei Huoxue Capsule in the treatment of syndrome of phlegm and blood stasis obstructing lung stage I silicosis. Chin J New Drugs (Zhongguo Xin Yao Za Zhi) 2019; 28(09): 1099–1103 (in Chinese)
Niu SQ, Hu YX, Cui YC, Zheng HG, Shi YP, Wang HJ. Therapeutic observation of acupuncture plus Shengmai Dihuang Decoction for coalminer’s pneumoconiosis due to lung-kidney qi deficiency. Shanghai J Acupunct Moxibustion (Shanghai Zhen Jiu) 2019; 38(09): 987–991 (in Chinese)
Zhang MR, Tang L, Shao LB, Yan XH, Li J. Investigation on anxiety and depression of pneumoconiosis patients and related influencing factors. China Occup Med (Zhongguo Zhi Ye Yi Xue) 2013; 40(01): 52–54 (in Chinese)
Qiu XX, Hao YT, Liang ZP, Xiao SJ, Wu XF, Chen CS, Lin AH. Study on correlative factors of the quality of life of pneumoconiosis patients. Chin J Health Stat (Zhongguo Wei Sheng Tong Ji Za Zhi) 2011; 28(03): 233–236 (in Chinese)
Acknowledgements
This work was supported by the Henan Province Priority and Advantage Discipline Construction Engineering Projects —Traditional Chinese Medicine (No. STS-ZYX-2017025) and the Special Project of Traditional Chinese Medicine Research in Henan Province (Nos. 20-21ZYZD01 and 2018ZY1003).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Jiansheng Li, Hulei Zhao, Yang Xie, Jieya Li, Qingwei Li, Xuexin Chen, and Weiyu Zhang declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. All procedures were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.
Rights and permissions
About this article
Cite this article
Li, J., Zhao, H., Xie, Y. et al. Clinical efficacy of comprehensive therapy based on traditional Chinese medicine patterns on patients with pneumoconiosis: a pilot double-blind, randomized, and placebo-controlled study. Front. Med. 16, 736–744 (2022). https://doi.org/10.1007/s11684-021-0870-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11684-021-0870-5